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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A135chondrocyte proliferation. The aim of the project is to test the
hypothesis that dysregulated expression of NHERF1 is a key part of the
abnormal behaviour of articular chondrocytes.
Methods: Full depth cartilage explants or shavings were removed from
osteoarthritic femoral heads or knee joints, and from healthy controls
(amputees or osteoporotic femoral heads). Explants from 17 patients (4
OA and 4 non-OA femoral heads, 4 OA knees and 5 amputees) were
decalciﬁed and ﬁxed in formalin for parafﬁn embedding and sectioning,
whilst shavings were placed in Dulbecco’s Modiﬁed Eagles Medium
(DMEM) and washed prior to enzymatic chondrocyte isolation. Sections
were deparafﬁnised and either stained with Fast-Green-FCF and
Safranin ‘O’, or treated with Target Retrieval Solution and hyaluronidase
prior to incubationwith glycine, blocking with non-immune serum and
overnight incubation with either rabbit anti-human NHE3 (pAb, C-20),
mouse anti-human NHERF1 (mAb, IgG2b), or goat anti-human PTEN
(pAb, N19) diluted in Dako Antibody Diluent (1:50: PTEN 1:100). Bound
NHE3, NHERF1 or PTEN antibodies were detected with goat anti-rabbit
(488 nm), goat anti-mouse (555 nm) or donkey anti-goat (488 nm)
secondary antibodies (1:100, PTEN 1:200) respectively. Sections were
mounted with Prolong Gold anti-fade mounting media containing DAPI
and visualized with a Zeiss Imager M2 ﬂuorescent or LSM 700 Zeiss
Imager M2 confocal laser scanning microscope (CLSM). Cell counts and
co-localisation were analysed using Image J software. Isolated articular
chondrocytes (n¼3) were incubated with BCECF-AM (5 mM, 15 mins, 37
oC), washed in DMEM without phenol red, aliquoted ( 14 x 104) and
placed in a sterile Ibidi m-Slide I (0.4) Flow Chamber (Thistle Scientiﬁc,
UK) for 20-30 min (37 oC) to attach. They were washed into the
appropriate saline,After saline washing, and BCECF was then alternately
excited at 488 nm and 458 nm, and emission collected at >505 nm
using a CLSM (Zeiss LSM 710) from individual cells. The background
from each wavelength was subtracted and the 488:458 nm ratio (R)
converted to pHi using a calibration curve constructed by per-
meabilizing the chondrocytes to Hþ in high-potassium (Kþ) solutions
of different pH containing nigericin (2 mM).
Results:NHE3, NHERF1 and PTENwere expressed in all zones of OA and
non-OA articular cartilage. Image J analysis showed that NHERF1 co-
localised with both proteins in the cytoplasm and perinuclear region,
but little was found near the cell membrane. It was also expressed in the
nucleus in 50% of chondrocytes in OA and non-OA samples. The median
diameter of the nuclei of OA chondrocytes was also found to be sig-
niﬁcantly larger (7.47 mm) than in non-OA chondrocytes (6.78 mm,
P¼0.001???). The pHi of normal, healthy chondrocytes was 6.9 þ 0.2
(n¼3) but OA chondrocytes appeared to bemore acidic. The pHi of these
chondrocytes was too low to be recorded successfully and reliably using
BCECF (pKa 6.98) which is used for measuring near neutral pH, so this
necessitated exploring the use of another ﬂuorescein derivative, DCFDA
(pKa 4.8) for pH measurements from pH 4-5
Conclusions: This is the ﬁrst study to identify NHE3, NHERF1 and PTEN
expression and co-localisation in human articular cartilage, and to
measure pHi in single isolated chondrocytes using confocal microscopy
and the ﬂuorescent dyes, BCECF-AM and DCFDA. NHERF1 was expected
at the cell membrane but, surprisingly, location was predominantly
cytoplasmic. Detection of NHERF1 expression and function in articular
cartilage may open new approaches for OA therapy in the future.
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ANALYSIS OF CARTILAGE BIOMARKERS OF AGING AND TURNOVER IN
THE OSTEOARTHROPATHY OF ALKAPTONURIA
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Purpose: Alkaptonuria (AKU) is a rare autosomal recessive disease that
results from a single enzyme deﬁciency in the tyrosine metabolic
pathway. As a result, homogentisic acid (HGA), a metabolite of tyrosine,
cannot be broken down; despite some urinary excretion, this results in
systemic increases in HGA concentrations. Over time, HGA undergoes
polymerization, termed ochronosis, and deposits as a polymer in col-
lagenous tissues. Typically this occurs in joint cartilages and leads to an
early onset, rapidly progressing osteoarthropathy. The literature sug-
gests that all AKU patients will develop osteoarthropathy, and many
will have multiple joint involvement. Little is currently known about
tissue turnover in cartilage affected by ochronosis and the impact of this
turnover on disease initiation and progression. We investigated theturnover of AKU cartilage using biomarkers of turnover and aging and
compared these to both OA and non-arthritic control cartilage tissues.
We hypothesized that novel age-related biomarkers would provide
insights into cartilage turnover in the context of AKU versus OA
cartilage.
Methods: Samples of hip and knee cartilage were obtained with
informed patient consent at the time of joint arthroplasty surgery for
arthropathy due to alkaptonuria (n¼6) and osteoarthritis (OA, n¼12).
Non-arthritic cartilages (n¼6) were obtained as waste tissues after
trauma surgery. We measured cartilage concentrations (normalized to
dry weight) of several biomarkers including glycosaminoglycan (GAG),
total cartilage oligomeric matrix protein (COMP) and two age-related
biomarkers, deamidated COMP (dCOMP) and aspartate ratio (Asp ratio
representing the proportion of racemized to total aspartate). Using the
nonparametric Mann-Whitney U test for unpaired data, biomarker
results from alkaptonuria samples were compared to results from OA
and non-OA normal samples.
Results: The cartilage samples used for this study represent almost 10%
of the known alkaptonuric population in the UK (knees n¼2, mean age
59.5 years and hips n¼4, mean age 61 years). Compared to both Non-OA
(knee n¼1, mean age 36 years and hip n¼5, mean age 63.4 years) and
OA (knee n¼5, mean age 68.6 years and hip n¼7, mean age 80.5 years)
samples, the mean amount of extractable protein from AKU cartilage
samples was signiﬁcantly greater (p¼0.002 and 0.035 respectively).
However, normalized to total protein, the mean amount of extractable
GAG (p<0.002) and total COMP (p<0.002) were signiﬁcantly lower in
AKU cartilage samples compared to both Non-OA and OA samples. The
age-related biomarkers, mean extractable dCOMP (expressed as a pro-
portion of total COMP) and mean Asp ratio, were both signiﬁcantly
higher in AKU cartilage samples compared to OA samples (p¼0.04 and
p¼0.004, respectively) but not relative to Non-OA cartilage.
Conclusions: To our knowledge these novel data represent the ﬁrst
examination of cartilage matrix components from patients with AKU,
compared with OA and non-arthritic normal controls. These data
demonstrate a signiﬁcantly reduced amount of extractable GAG and
COMP suggestive of an impaired anabolic response. Further support for
lack of appropriate repair response in AKU cartilages was provided by
the results for the age-related biomarkers; both age-related biomarkers
were enriched in AKU relative to OA cartilages suggesting lack of an
anabolic response in degenerating cartilage in AKU. These data suggest
that individuals with AKU may beneﬁt from growth factor and other
anabolic treatments as there appears to be a lack of an anabolic
response to the cartilage degeneration associated with the pathological
ochronotic pigmentation process.
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ELEVATED EXPRESSION OF PERIOSTIN IN HUMAN OSTEOARTHRITIS
CARTILAGE AND ITS POTENTIAL ROLE IN MATRIX DEGRADATION
VIA MMP-13
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Purpose: The synovium, bone, and cartilage are each involved in
pathologic processes that lead to progressive joint degeneration. In
concert with cartilage degeneration, the subchondral plate in knee
joints affected by OA has been shown to have increased bone volume
fraction and trabecular thickness, but reduced tissue mineral density,
consistent with OA being associated with abnormalities in bone turn-
over. We have identiﬁed, using Affymetrix microarray screening and
conﬁrmatory QPCR, that periostin - an osteoblast stimulatory factor
encoded by the gene Postn - is signiﬁcantly overexpressed by chon-
drocytes and subchondral bone in OA.We have also found that periostin
mRNA expression in cartilage is increased in both rat meniscectomy
(MM) and anterior crucial ligament (ACL) surgical models of OA. This
study investigates its expression in rodent models of OA and regulation
of chondrocyte metabolism.
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(age 45-80 years) undergoing knee replacement surgery. Non-arthritic
knee cartilages were obtained from autopsy patients within 24h (NDRI,
Philadelphia). Three different rodent OA models, such as anterior cru-
ciate ligament transection (ACLT) and medial meniscectomy (MM) and
combination of both ACLT and MM models were performed. Prede-
signed TaqMan PCR primers were purchased from Applied Biosystems.
siRNA targeting periostin were purchased from Sigma. Matrix metal-
loproteinases proMMP-1 and proMMP-13 ELISA kits were from R&D
Systems. Degradation products of type II collagen was measured using
C1,2C - ELISA assay kit.
Results: Elevated expression of periostin (2-4 fold; p¼0.004) was
observed in OA compared to non-diseased control cartilage. Veriﬁcation
by real-time PCR, immunohistochemistry and immunoblot conﬁrmed
periostin upregulation in OA cartilage. In three different model of sur-
gical-induction of OA in rodents, such as anterior cruciate ligament
transection (ACLT) and destabilization of the medial meniscus (DMM)
and combination of both ACLT and MM models, periostin expression
signiﬁcantly increased (3-11 fold; p¼0.001) from 4-8 weeks after sur-
gery. In functional assays, exogenously added (1-10 mg/ml) or adeno-
virus mediated overexpression of periostin signiﬁcantly increased
MMP-13 (p<0.001) and ADAMTS4 (p<0.03) expression and activity
(p<0.02) in primary human OA and mouse chondrocytes. Conversely;
knock down of endogenous periostin using siRNA signiﬁcantly
decreased constitutive MMP-13 expression. In OA cartilage explants
cultures, periostin increased cartilage degradation, evidenced by
increased release of collagen (C1, 2C) and GAG fragments in culture
supernatants. Periostin selectively activates Wnt signaling and induc-
tion of MMP-13 and ADAMTS4 expression is mediated by b-catenin
signaling and inhibited by the Wnt inhibitor CCT031374 hydrobromide.
Conclusions: These ﬁndings characterize periostin as a catabolic
extracellular matrix protein in OA cartilage, where it acts via the can-
onical Wnt signaling pathway to promote cartilage degradation by
upregulating MMP-13 and aggrecanase expression. Therefore, periostin
may represent a novel therapeutic target to prevent OA progression.
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CARTILAGE SPECIFIC DELETION OF MITOGEN INDUCIBLE GENE 6 IN
MICE INCREASES ARTICULAR CARTILAGE THICKNESS IN LATE
ADULTHOOD
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Purpose: Osteoarthritis (OA) is a degenerative joint disease which is
characterized by the progressive loss of articular cartilage thickness and
overall joint degeneration. There are currently no treatments to slow,
stop or reverse joint destruction, and so therapeutics for OA only mit-
igate symptoms of pain/stiffness. Mitogen inducible gene 6 (Mig-6)
negatively regulates epidermal growth factor (EGFR) signalling which is
important in cartilage homeostasis (Appleton et al, 2010). We have
shown previously that loss of Mig-6 in mouse cartilage results in
increased articular cartilage thickness and ectopic formation of chon-
dro-osseous nodules in the knee (Pest et al, 2014). However, it is unclear
whether these anabolic effects are observed in other joints, and if
altered cartilage homeostasis can be induced post-natally.
Purpose: To determine 1) the role of Mig-6 in maintaining cartilage
anabolism when deleted in post-natal mouse cartilage, 2) the anabolic
effects of Mig-6 loss in multiple joints and at multiple ages, and 3)
whether this phenotype can be rescued by deletion of EGFR ligand
TGFalpha.
Methods: Selective knockout of Mig-6 in cartilage was achieved
through the use of the Cre-lox system, by breeding “ﬂoxed”Mig-6 (Mig-
6ﬂ/ﬂ) mice to either animals with Cre driven by Col2a1 promoter (Col2-
Creþ/-) or to animals with an inducible Col2a1 driven Cre (Col2a1-
CreERT2þ/-). Col2-Cre mice were aged to 15 and 21 months of age to
examine cartilage anabolism and formation of ectopic chondro-osseous
nodules late in life. 21 month old mice were scanned by MicroCT at 50
mm/voxel resolutions to examine changes in bone morphology and
ectopic nodule formation. Cre-mediated recombination in Col2-CreER
mice was induced by 5 day tamoxifen injection in 3week old mice. Mice
with deletion of TGFalpha were bred to Mig-6 KO mice to evaluate the
role of this EGFR ligand in the anabolic phenotype. Histological sections
of knee, ankle, elbow and spine articular joints were collected and joint
morphology was examined using various stains including Safranin O/fast green, toluidine blue and picrosirius red. Immunohistochemistry
(IHC) was used to evaluate molecular changes in joint tissues.
Results: Anabolic increase in the cartilage thickness of the elbow and
ankle was observed up to the age of 21 months in Mig-6 knockout mice
(KO, Mig-6ﬂ/ﬂ;Col2-Creþ/-) when compared to Control mice (Mig-6ﬂ/
ﬂ;Col2-Cre-/- or Mig-6ﬂ/þ;Col2-Cre-/-). Ectopic chondro-osseous nod-
ules were identiﬁed only in the knee joints and spines of KO mice by
MicroCT evaluation and histology. Phospho-ERK staining in these tis-
sues was increased in KO mice compared to control, indicating
increased EGFR signalling. Deletion of TGFalpha in Mig6 KO did not
prevent formation of chondro-osseous nodules in the knee as late as 12
weeks of age.
Conclusions: The anabolic effects of Mig6 loss in mouse cartilage can
persist late into adulthood, however the exact mechanism is still
unclear. Mig6 and the EGFR signalling pathway may be promising tar-
gets for the development of therapeutic interventions which induce
cartilage anabolism and repair in OA diseased tissue.
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XENOESTROGENS DISRUPT TYPE 2 COLLAGEN EXPRESSION IN
CHONDROCYTES IN VITRO.
M.T. Corvol, Sr., T. Auxietre, M.-F. Dumontier, O. Kellerman,
J.-F. Savouret. INSERM, Paris, France
Purpose: In recent years chemicals with endocrine properties, called
Endocrine Disrupting Compounds (EDC), have become a topic of sci-
entiﬁc and public discussion. In the ﬁeld of osteoarthritic pathologies,
EDC compounds that mimic estrogenic agonists or antagonists are of
major concern, because of the central role of estrogens in skeletal
developmental processes (ref). EDC are acting on their target genes
upon binding the aryl hydrocarbon receptor (AhR). During the ten past
years, interactions between estrogen receptor (ER) and some xeno-
biotic-activated AhR have been well demonstrated. Very few studies
have been reported on EDC effects on bone or cartilage. Our laboratory
recently studied the effects of low doses and cocktail xenoestrogens on
rat cartilage development in vivo, by using a rodent gestational/lacta-
tional model (T.A. Auxietre, et al, 2014). We observed transient mod-
iﬁcations of caudal vertebral body associated with a decrease in growth
plate cartilage thickness with greater impact on the hypertrophic
chondrocyte zone. We inferred from these data that the tested com-
pounds could interfere with the dynamic of chondrogenic differ-
entiation and/or maturation processes, possibly by impacting type 2
collagen (Col2), one of the the major components of cartilage that
assures cartilage function.
The present work was aimed to study the in vitro effects of two xen-
oestrogens (genistein, G; bisphenol A, BPA) and one anti-androgen
(vinclozolin, V) and its metabolite M2 on Col2 expression in two dif-
ferent models of cultured chondrocytes: during the process of chon-
drogenic induction and in mature chondrocytes.
Methods: A murine stem cell line inducible towards chondrogenesis
(C1) was used for dynamic studies of differentiation using chondrogenic
and non-chondrogenic markers. In parallel, post-natal murine chon-
drocytes were used for steady-state investigations in differentiated
chondrocytes in primary culture (P0) or after dedifferentiation by pas-
sages (P3) or FGF2 treatment. Biological markers were studied at the
mRNA (qPCR) and protein (western blot) levels. COL2A protein
expression was evaluated by western blot and immunocytochemistry
by using an antibody which only recognizes the speciﬁc COL2A N-ter-
minal propeptide. Fulvestrant and SB 203580 were used respectively as
speciﬁc inhibitors of ER or p38MEK pathways. Implication of Tia1-
splicing was shown after cell transfectionwith speciﬁc anti-Tia1 siRNAs.
Results: Vinclozolin was practically inactive. M2, alone or combined
with G or BPA, modiﬁed the dynamic of Col2A immature isoform of
COL2 during chondrogenic induction. These compounds extended the
basal expression of COL2A and delayed its replacement by the mature
isoform COL2B in C1 cells. This effect was dose dependent with max-
imum at 10-6M. In post natal chondrocytes, COL2A expression
increased with cell dedifferentiation or FGF2 treatment. EDC were
inactive on differentiated chondrocytes while COL2A doubled upon M2,
G and BPA addition in dedifferentiated cells. Estrogen receptor (ER) and
the p38-MEK pathway were involved. As these effects were only partly
transcriptional, we investigated and found an effect of FGF2 on Tia-1
splice protein expression. EDC showed no effects on other chondrogenic
markers (SOX9, Aggrecan, Col10a1) nor non-chondrogenic markers.
